High-grade invasive urothelial carcinoma with focal plasmacytoid differentiation successfully treated by transurethral resection followed by chemoradiotherapy-Reference-Cited by-同舟云学术

High-grade invasive urothelial carcinoma with focal plasmacytoid differentiation successfully treated by transurethral resection followed by chemoradiotherapy

Published:2011-10-17 Issue:12 Volume:18 Page:851-853
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:

Author:

Kawahara Takashi,Oshiro Hisashi,Sekiguchi Zenkichi,Ito Hiroki,Makiyama Kazuhide,Uemura Hiroji,Kubota Yoshinobu

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1442-2042.2011.02880.x/fullpdf

Reference10 articles.

1. Plasmacytoid urothelial carcinoma of the urinary bladder report of seven new cases;Mai;Eur. Urol.,2006

2. Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer;Chalasani;Can. Urol. Assoc. J.,2009

3. Plasmacytoid urothelial carcinoma of the bladder: histological and clinical features of 5 cases;Fritsche;J. Urol.,2008

4. Plasmacytoid urothelial carcinoma of the bladder;Lopez-Beltran;Hum. Pathol.,2009

5. Plasmacytoid transitional cell carcinoma. Report of a case with initial presentation mimicking multiple myeloma;Sahin;Acta Cytol.,1991

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Muscle Invasive Bladder Cancer with Variant Histology: Biological Features and Clinical Implications;Oncology;2021

2. Histological Variants—Plasmacytoid Bladder Cancer;Management of Non-Muscle Invasive Bladder Cancer;2019-10-24

3. A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy;BioMed Research International;2017

4. Invasive urothelial carcinoma, lymphoma-like/plasmacytoid variant, successfully treated by radical cystectomy with adjuvant chemotherapy: a case report;Journal of Medical Case Reports;2016-03-08

5. Pretreatment Neutrophil-to-Lymphocyte Ratio Can Predict the Prognosis in Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy;BioMed Research International;2016